<DOC>
	<DOCNO>NCT02522312</DOCNO>
	<brief_summary>A retrospective analysis Restasis® benefit dry eye contact lens patient .</brief_summary>
	<brief_title>A Retrospective Analysis Restasis® Benefits Dry Eye Contact Lens Patients</brief_title>
	<detailed_description>Charts contact lens wearer diagnose dry eye treat Restasis evaluate determine success treatment retrospectively look various outcome measure include limited schirmer , stain osmolarity level</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>Male Female , &gt; = 18 year age Subject previously diagnose ( prior Baseline Visit ) mild severe dry eye disease ( ITF level 1 , 2 3 ) require continuous medical therapy Restasis® minimum duration 6 month postBaseline ( Visit 1 ) ; Subject newly diagnose ( Baseline Visit ) mild severe dry eye disease ( ITF level 1 , 2 3 ) require continuous medical therapy Restasis® minimum duration 6 month postBaseline ( Visit 1 ) ; Subject prescribe Restasis® therapy Baseline Visit ( Visit 1 ) commence dose immediately Baseline Visit ( Visit 1 ) Baseline Visit occur 01 July 2012 01 January 2014 ; Subject corneal stain least one dry eye sign ( i.e. , Schirmer 's Test score &lt; 10 mm , decrease tear lake , TBUT &lt; 10 second , conjunctival staining , tear osmolarity &gt; 310 mOsmol/L Subject chart tolerability efficacy data reflect least one followup visit follow Restasis® treatment initiation ; Subject wear contact lens ( e ) concurrently receive Restasis® treatment minimum duration 6 month postBaseline ( Visit 1 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Dry Eye</keyword>
</DOC>